16.Drucker DJ, Buse JB, Taylor K, Kendall DM, Trautmann M, Zhuang D, Porter L, DURATION-1 Study Group 2008 Exenatide once weekly versus twice daily for the treatment of type 2 diabetes:a randomised, open-label, non-inferiority study. Lancet 372:1240–1250 17.Best JH, Boye KS, Rubin RR, Cao D, Kim TH, Peyrot M 2009 Improved treatment satisfaction and weight-related quality of lifewith exenatide once weekly or twice daily. Diabet Med 26:722–728 18.World Medical Association declaration of Helsinki 1997 Recom- mendations guiding physicians in biomedical research involving hu-man subjects JAMA 277:925–926 19.Amylin Pharmaceuticals Inc. 2009 BYETTA ®exenatide injection [prescribing information]. San Diego: Amylin Pharmaceuticals, Inc. 20.Fineman MS, Bicsak TA, Shen LZ, Taylor K, Gaines E, Varns A, Kim D, Baron AD 2003 Effect on glycemic control of exenatide (synthetic exendin-4) additive to existing metformin and/or sulfo-nylurea treatment in patients with type 2 diabetes. Diabetes Care